Polaris Global Equity Composite Q1 2026 Commentary

Why It Matters

The outperformance underscores the value of a truly global, diversified equity approach when U.S. markets face rate‑driven headwinds and geopolitical shocks, signaling a shift away from a US‑centric bias.

Key Takeaways

• Composite up 5.9% YTD, MSCI World down 3.5% in Q1 2026.
• Energy and IT sectors drove double‑digit gains amid Hormuz crisis.
• US exposure underweight yet contributed strongest regional performance.
• Materials stocks like Methanex boosted returns from supply‑shock price spikes.
• Added Eastman Chemical and Ryanair; exited Capgemini and UnitedHealth.

Pulse Analysis

The first quarter of 2026 highlighted how macro‑policy and geopolitical events are reshaping global equity markets. With the Federal Reserve holding rates at 3.5%‑3.75% and the European Central Bank and Bank of Japan on hold, investors faced a backdrop of higher financing costs. The sudden closure of the Strait of Hormuz amplified oil and nitrogen price volatility, creating sharp sector rotations that rewarded energy, materials and defensive stocks while penalizing more cyclical, AI‑driven names. This environment reinforced the case for broad international exposure, as reliance on a single market can magnify the impact of regional shocks.

Polaris’s Global Equity Composite capitalized on these dynamics, delivering a 5.91% net gain versus a 3.47% decline in the MSCI World benchmark. Energy giants such as ENI, Marathon Petroleum and TotalEnergies led the charge, while IT players like SK Hynix and Samsung benefited from a chip shortage that drove record wafer‑fab orders. Materials firms, notably Methanex, turned supply‑chain disruptions into profit opportunities, and healthcare names such as Gilead posted double‑digit jumps on breakthrough oncology data. The fund’s regional tilt—underweight in the United States yet still drawing strong performance—illustrates how selective exposure to high‑conviction names can outperform broader indices.

Looking ahead, the portfolio manager emphasizes a disciplined search for dislocations created by ongoing volatility. Recent trades—adding Eastman Chemical and Ryanair while exiting Capgemini and UnitedHealth—reflect a focus on quality businesses with clear catalysts and attractive valuations. The broader strategic message is clear: investors are increasingly recognizing that a diversified global stance, rather than a US‑centric one, is essential for navigating a world where rate hikes, geopolitical tensions, and commodity shocks are likely to persist. This shift could drive more capital toward internationally diversified funds, reshaping asset allocation trends over the coming years.